Home BUSINESS News Amgen Agrees to Deal to Buy Horizon Therapeutics

Amgen Agrees to Deal to Buy Horizon Therapeutics

0
Amgen Agrees to Deal to Buy Horizon Therapeutics

[ad_1]

The U.S. biotechnology company will pay $116.50 for each Horizon share

[ad_2]

Source link